NPNK.F Stock Overview

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. More details

NPNK.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	4/6
Financial Health	6/6
Dividends	5/6

Rewards

Trading at 42.4% below our estimate of its fair value

Earnings are forecast to grow 6.81% per year

Earnings grew by 11.6% over the past year

Pays a reliable dividend of 2.15%

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Nippon Shinyaku Co., Ltd. Competitors

Supernus Pharmaceuticals

NasdaqGM:SUPN

US$2.0b

Prestige Consumer Healthcare

NYSE:PBH

US$3.9b

Organon

NYSE:OGN

US$3.8b

Amphastar Pharmaceuticals

NasdaqGS:AMPH

US$1.8b

Price History & Performance

Summary of share price highs, lows and changes for Nippon Shinyaku
Historical stock prices
Current Share Price	JP¥41.82
52 Week High	JP¥56.45
52 Week Low	JP¥41.82
Beta	0.090
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	321.59%

Recent updates

Shareholder Returns

	NPNK.F	US Pharmaceuticals	US Market
7D	0%	0.6%	-0.4%
1Y	n/a	10.0%	24.8%

Return vs Industry: Insufficient data to determine how NPNK.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how NPNK.F performed against the US Market.

Price Volatility

Is NPNK.F's price volatile compared to industry and market?
NPNK.F volatility
NPNK.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.5%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: NPNK.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NPNK.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1911	2,186	Toru Nakai	www.nippon-shinyaku.co.jp

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases.

Nippon Shinyaku Co., Ltd. Fundamentals Summary

How do Nippon Shinyaku's earnings and revenue compare to its market cap?
NPNK.F fundamental statistics
Market cap	US$2.51b
Earnings (TTM)	US$155.58m
Revenue (TTM)	US$971.48m

16.1x

P/E Ratio

2.6x

P/S Ratio

Is NPNK.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NPNK.F income statement (TTM)
Revenue	JP¥145.57b
Cost of Revenue	JP¥55.01b
Gross Profit	JP¥90.55b
Other Expenses	JP¥67.24b
Earnings	JP¥23.31b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Nov 13, 2023

Earnings per share (EPS)	346.12
Gross Margin	62.21%
Net Profit Margin	16.01%
Debt/Equity Ratio	0%

How did NPNK.F perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

33%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/24 11:29
End of Day Share Price	2023/07/27 00:00
Earnings	2023/06/30
Annual Earnings	2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nippon Shinyaku Co., Ltd. is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tatsuyuki Arai	BofA Global Research
Hidemaru Yamaguchi	Citigroup Global Markets Japan Inc.
Hidemaru Yamaguchi	Citigroup Inc